Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals elevated cardiac troponin I correlates with higher stroke severity and mortality in acute ischemic stroke, indicating its utility as a prognostic marker.
Aim The aim of this study is to explore the correlation between cardiac troponin I (cTnI) levels and the National Institutes of Health Stroke Scale (NIHSS) in acute ischemic stroke (AIS) patients as well as to determine the significance of cTnI levels in predicting the prognosis of AIS patients. Methods A retrospective analysis was conducted on patients diagnosed with AIS who presented to the Emergency Department of Ankara Dışkapı Yıldırım Beyazıt Research and Training hospital between February and June 2018 and had their cTnI levels assessed. Both the cTnI levels and NIHSS scores of these patients were documented. Results A total of 151 patients were evaluated. The mortality rate for patients with normal cTnI levels was 1.69% (2 out of 118 patients), while those with elevated cTnI levels had a mortality rate of 32.25% (*P* = .001). Of those with normal cTnI levels, 10.92% required intensive care unit (ICU) admission, compared to 40.62% with elevated cTnI levels (*P* = .002). The average NIHSS scores for patients with normal and high cTnI levels were 5.83 ± 5.80 and 12.56 ± 7.55, respectively. Conclusion The results of this study indicate that elevated cTnI levels in AIS patients are associated with a worse prognosis, higher necessity for ICU admission, and increased mortality rates. It is believed that evaluating cTnI levels, a readily available test in AIS patients, will guide clinicians in assessing the patient’s prognosis.
No takes yet. Share an insight, caveat, or question.
Chatıp et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: